RORing CAR T cells in solid and hematologic cancers: Same but different.
    
    
        
    
    
        
        Clin. Cancer Res. 31, 437-438 (2025)
    
    
 	
    
	
	  DOI
 DOI
	  PMC
 PMC
		
		
			Open Access Green as soon as Postprint is submitted to ZB.
		
     
    
      
      
	
	    A recent phase I clinical study tested anti-ROR1 chimeric antigen receptor (CAR) T cells in patients with chronic lymphocytic leukemia, non–small cell lung cancer, and triple-negative breast cancer. The product could be safely administered and had activity in chronic lymphocytic leukemia but less so in non–small cell lung cancer and triple-negative breast cancer.
	
	
	    
	
       
      
	
	    
		Impact Factor
		Scopus SNIP
		Web of Science
Times Cited
		Scopus
Cited By
		Altmetric
		
	     
	    
	 
       
      
     
    
        Publication type
        Article: Journal article
    
 
    
        Document type
        Comment, Opinion
    
 
    
        Thesis type
        
    
 
    
        Editors
        
    
    
        Keywords
        
    
 
    
        Keywords plus
        
    
 
    
    
        Language
        english
    
 
    
        Publication Year
        2025
    
 
    
        Prepublished in Year
        0
    
 
    
        HGF-reported in Year
        2025
    
 
    
    
        ISSN (print) / ISBN
        1078-0432
    
 
    
        e-ISSN
        1557-3265
    
 
    
        ISBN
        
    
    
        Book Volume Title
        
    
 
    
        Conference Title
        
    
 
	
        Conference Date
        
    
     
	
        Conference Location
        
    
 
	
        Proceedings Title
        
    
 
     
	
    
        Quellenangaben
        
	    Volume: 31,  
	    Issue: 3,  
	    Pages: 437-438 
	    Article Number: ,  
	    Supplement: ,  
	
    
 
    
        
            Series
            
        
 
        
            Publisher
            American Association for Cancer Research (AACR)
        
 
        
            Publishing Place
            615 Chestnut St, 17th Floor, Philadelphia, Pa 19106-4404 Usa
        
 
	
        
            Day of Oral Examination
            0000-00-00
        
 
        
            Advisor
            
        
 
        
            Referee
            
        
 
        
            Examiner
            
        
 
        
            Topic
            
        
 
	
        
            University
            
        
 
        
            University place
            
        
 
        
            Faculty
            
        
 
    
        
            Publication date
            0000-00-00
        
 
         
        
            Application date
            0000-00-00
        
 
        
            Patent owner
            
        
 
        
            Further owners
            
        
 
        
            Application country
            
        
 
        
            Patent priority
            
        
 
    
        Reviewing status
        Peer reviewed
    
 
    
        Institute(s)
        Unit for Clinical Pharmacology (KKG-EKLiP)
    
 
    
        POF-Topic(s)
        30203 - Molecular Targets and Therapies
    
 
    
        Research field(s)
        Immune Response and Infection
    
 
    
        PSP Element(s)
        G-522100-001
    
 
    
        Grants
        The m4 Award of the Bavarian Ministry for Economic Affairs
Bavarian Research Foundation (BAYCELLATOR)
Go-Bio-Initiative
Monika Kutzner Foundation for Cancer Research
Institutional Strategy LMUexcellent of LMU Munich
Hector Foundation
Ernst Jung Stiftung
Wilhelm-Sander-Stiftung
German Cancer Aid (AvantCAR.de)
Else Kroener-Fresenius-Stiftung (IOLIN)
Marie Sklodowska-Curie Training Network for Optimizing Adoptive T Cell Therapy of Cancer by European Union
Melanoma Research Alliance
Elite Network of Bavaria
Deutsche Forschungsgemeinschaft
Bruno and Helene Joester Foundation (360degrees CAR)
Bundesministerium fuer Bildung und Forschung
European Research Council
Deutsche Jose Carreras Leukaemie Stiftung
SFB-TRR-Fritz-Bender Foundation
Bavarian Cancer Research Center (TANGO)
    
 
    
        Copyright
        
    
 	
    
    
    
    
    
        Erfassungsdatum
        2025-04-09